Cardiac involvement in primary myopathies

Cardiology

Volumn 94, Issue 1, 2000, Pages 1-11

  Finsterer, J ^a,c   Stollberger C ^b  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^c NONE   (Austria)

Author keywords

Echocardiography; Electrocardiogra phy; Electromyography; Genetics; Heart; Muscle; Neuromuscular disorders

Indexed keywords

CONTRACTILE PROTEIN;

COMORBIDITY; CORONARY ARTERY DILATATION; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ELECTROMYOGRAPHY; GENETIC ANALYSIS; HEART DILATATION; HEART FAILURE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VENTRICLE HYPERTROPHY; HUMAN; INTRACARDIAC THROMBOSIS; METABOLIC DISORDER; MYOCARDIAL DISEASE; MYOPATHY; NEUROMUSCULAR DISEASE; PRIORITY JOURNAL; REVIEW; VALVULAR HEART DISEASE;

EID: 0033662464     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007039     Document Type: Review

References (123)

1. Cardiac muscle involvement in muscle disorders
2. Emerin and cardiomyopathy in Emery-Dreifuss muscular dystrophy
3. Cardiomyopathy in Duchenne, Becker, and sarcoglycanopathies: A role for coronary dysfunction?
4. ECG abnormalities in myopathies, coronary heart disease and controls
5. Cardiac involvement in patients with myotonic dystrophy, Becker's muscular dystrophy and mitochondrial myopathy
6. Progression of cardiac involvement in patients with myotonic dystrophy, Becker's muscular dystrophy and mitochondrial myopathy during a two-year follow-up
7. Complex mitochondriopathy associated with four mtDNA transitions
8. Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy
9. A female carrier of Duchenne muscular dystrophy complicated with cardiomyopathy
10. Dystrophies and heart disease
11. X-chromosomal (p21) muscular dystrophy and left ventricular diastolic and systolic function
12. Left ventricular non-compaction in a patient with Becker's muscular dystrophy
13. Cardiac transplantation in a Duchenne muscular dystrophy carrier
14. Pathogenesis of inherited forms of dilated cardiomyopathy
15. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy
16. Haemostatic abnormalities, cardiac involvement and serum tumor necrosis factor levels in X-linked dystrophic patients
17. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction system disease
18. Emerin
19. Emery-Dreifuss muscular dystrophy
20. Cardiac involvement in Emery-Dreifuss muscular dystrophy: A case series
21. Facioscapulohumeral muscular dystrophy
22. The heart in Becker muscular dystrophy, facioscapulohumeral dystrophy, and Bethlem myopathy
23. The heart in muscular dystrophy: An electrocardiographic and ultrasound study of 20 patients
24. Cardiac deformity and dysfunction in facioscapulohumeral dystrophy - Electrocardiogram, ECG gate cardiac MRI studies
25. Cardiac involvement in facio-scapulo-humeral muscular dystrophy: A family study using thallium-201 single-photon-emission-computed tomography
26. Cardiac involvement in genetically confirmed facioscapulohumeral muscular dystrophy
27. Heart involvement in muscular dystrophies due to sarcoglycan gene mutations
28. Radiofrequency catheter ablation for atrial flutter following orthotopic heart transplantation
29. The heart in limb girdle muscular dystrophy
30. Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by beta-sarcoglycan mutations
31. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: A novel mechanism for cardiomyopathy and muscle dystrophy
32. The Fukuyama congenital muscular dystrophy story
33. Congenital muscular dystrophy of the Fukuyama type (FCMD) with severe myocardial fibrosis. A case report with postmortem angiography
34. The life spans, cause of death and pathological findings of Fukuyama-type congenital muscular dystrophy - Analysis of 24 autopsy cases
35. The myotonic dystrophies
36. Myotonic heart disease: A clinical follow-up
37. Myotonic dystrophy associated with QT prolongation and torsades de pointes
38. 'Hypertrophic cardiomyopathy' in a girl with adult-type myotonic dystrophy
39. Left ventricular diastolic function in congenital myotonic dystrophy
40. Cardiac disease in myotonic dystrophy
41. Localization of the sites of conduction abnormalities in a mouse model of myotonic dystrophy
42. Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy
43. Clinical and genetic characteristics of a five-generation family with a novel form of myotonic dystrophy (DM2)
44. A patient with muscle pain after a journey to the tropics. Myocardial involvement in proximal myotonic myopathy
45. Cardiac involvement in proximal myopathy
46. Neuromuscular disorders: Gene location
47. An interesting case of infant sudden death: Severe hypertrophic cardiomyopathy in Pompe's disease
48. Glycogenosis type IV as a seldom cause of cardiomyopathy - Report about a successful heart transplantation
49. Angina for 14 years
50. Infantile hypertrophic cardiomyopathy of glycogenosis type IX: Isolated cardiac phosphorylase kinase deficiency
51. Mitochondrial encephalomyopathies: Back to mendelian genetics
52. Mitochondrial myopathies: What next?
53. The mitochondrial myopathies
54. Mitochondrial respiratory chain disorders. I. Mitochondrial DNA defects
55. Mitochondrial respiratory chain disorders. II. Neurodegenerative disorders and nuclear gene defects
56. A novel deficiency of mitochondrial ATPase of nuclear origin
57. Mitochondrial defects in cardiomyopathy and neuromuscular disease
58. Hypertrabeculated left ventricle in mitochondriopathy
59. Isolated left ventricular abnormal trabeculation in adults is associated with neuromuscular disorders
60. Maternally inherited cardiomyopathy: Clinical and molecular characterization of a large kindred harboring the A4300G point mutation in mitochondrial deoxyribonucleic acid
61. Cardiac transplantation in an incomplete Kearns-Sayre syndrome with mitochondrial DNA deletion
62. Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy
63. Coexistence of mitochondrial DNA and beta-myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure
64. From dystrophinopathy to sarcoglycanopathy: Evolution of a concept of muscular dystrophy
65. Exercise responses after cardiac transplantation in mitochondrial myopathy
66. Cardiac transplantation for hypertrophic cardiomyopathy associated with Senger's syndrome
67. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator
68. Myopathy in very-long-chain acyl-CoA dehydrogenase deficiency: Clinical and biochemical differences with the fatal cardiac phenotype
69. Molecular heterogeneity in very-long-chain acyl-CoA dehydrogenase deficiency causing pediatric cardiomyopathy and sudden death
70. Myoadenylate deaminase deficiency in children
71. Myoadenylate deaminase deficiency, hypertrophic cardiomyopathy and gigantism syndrome
72. Two novel missense mutations of the OCTN2 gene (W283R and V446F) in a patient with primary systemic carnithine deficiency
73. Lysosomal glycogen storage with normal acid maltase: A familial study with successful heart transplant
74. Lysosomal glycogen storage disease with normal acid maltase with early fatal outcome
75. Restrictive cardiomyopathy, atrioventricular block and mild to subclinical myopathy in patients with desmin-immunoreactive material deposits
76. Autosomal dominant myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy linked to chromosome 10q
77. Desmin myopathy involving cardiac, skeletal, and vascular smooth muscle: Report of a case with immunoelectron microscopy
78. The absence of desmin leads to cardiomyocyte hypertrophy and cardiac dilation with compromised systolic function
79. Familial cardiomyopathy and distal myopathy with abnormal desmin accumulation and migration
80. Cardiomyopathy and multicore myopathy with accumulation of intermediate filaments
81. Dilated cardiomyopathy in multicore myopathy
82. Multicore myopathy: Not always a benign entity
83. Familial cardiomyopathy, mental retardation and associated with desmin-type intermediate filaments
84. A nemaline myopathy mutation in alpha-tropomyosin causes defective regulation of striated muscle force production
85. Mutations in the skeletal muscle α-actin gene in patients with actin myopathy and nemaline myopathy
86. Nemaline myopathy: Two autopsy reports
87. Congenital nemaline myopathy with dilated cardiomyopathy: An autopsy study
88. Heart transplantation in a patient with central core disease
89. The safety of dantrolene in a patient with a severe cardiomyopathy requiring a heart transplant
90. Cardiac manifestations of congenital fibre-type disproportion myopathy
91. The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies
92. Possible X-linked congenital mitochondrial cardiomyopathy in three families
93. Xq28-linked noncompaction of the left ventricular myocardium: Prenatal diagnosis and pathologic analysis of affected individuals
94. Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome
95. Decreased expression of laminin-beta-1 in chromosome 21-linked Bethlem myopathy
96. Inherited disorders of the extracellular matrix
97. McLeod syndrome: A distinct form of neuroacanthocytosis. Report of two cases and literature review with emphasis on neuromuscular manifestations
98. Troponin I as a specific marker for heart damage after heart transplantation in a patient with Becker-type muscular dystrophy
99. Dilated cardiomyopathy requiring cardiac transplantation as initial manifestation of Xp21 Becker-type muscular dystrophy
100. Cardiac transplantation in Becker muscular dystrophy
101. Maternally inherited cardiomyopathy: Clinical and molecular characterization of a large kindred harboring the A4300G point mutation in mitochondrial deoxyribonucleic acid
102. A family with facioscapulohumeral muscular dystrophy and hereditary long QT syndrome
103. Cardiac involvement in patients with myotonic dystrophy: Characteristic features of magnetic resonance imaging
104. Doppler echocardiographic assessment of left ventricular diastolic function in myotonic dystrophy
105. Inherited disorders of sarcomeric proteins
106. Genetic analysis of the G4.5 gene in families with suspected Barth syndrome
107. Cardiac involvement in Becker's muscular dystrophy, necessitating heart transplantation, 6 years before apparent skeletal muscle involvement
108. Multiple coronary arteriovenous fistulas in a patient who had an orthotopic heart transplant
109. Cardiomyopathy in Becker muscular dystrophy
110. Heart transplantation in patients with muscular dystrophy associated with end-stage cardiomyopathy
111. Dilating cardiomyopathy as the expression of Xp21 Becker-type muscular dystrophy
112. Cardiac manifestations and their management in Becker's muscular dystrophy
113. Cardiac transplantation in a patient with muscular dystrophy and cardiomyopathy
114. Serum antibodies to the deleted dystrophin sequence after cardiac transplantation in a patient with Becker's muscular dystrophy
115. Heart transplantation in patients with 'so-called' contraindications
116. Cardiac transplantation in Becker muscular dystrophy
117. A 22-year-old man with cardiac transplant and creatine kinase elevation
118. Multiple mitochondrial DNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy
119. Cardiac transplantation in female Emery-Dreifuss muscular dystrophy
120. Dominant autosomal humeroperoneal syndrome with early contractures and cardiomyopathy (Emery-Dreifuss syndrome)
121. Severe cardiomyopathy revealing amylopectinosis: Two cases in adolescence from the same family
122. Heart transplantation for Barth syndrome
123. Aortic valve replacement thirty-one months after orthotopic heart transplantation